Public Release: 23-Jun-2016 WHO’S TB care advice violated standards, researchers say Poor countries told to follow cheaper, untested treatments Duke University DURHAM, N.C. — The World Health Organization (WHO) violated sound standards of medical care and human rights by nudging… Read More ›
Corruption – Fabricated Data
Pharma Firms may of got caught manipulating data, resulting in agony and profit ?
“misleading marketing caused some lung-cancer patients “to die earlier and faster, with more pain.” “This settlement, however, allows the company to avoid the burden, disruption, cost and distraction of protracted civil litigation and to focus instead on our business of… Read More ›
FDA approved devices were not effective in clinical trials
Public Release: 20-May-2016 Flawed data behind regulation of high-risk women’s health devices Some FDA approved devices were not effective in clinical trials Northwestern University CHICAGO — Some high-risk medical devices used in obstetrics and gynecology were approved by the FDA… Read More ›
Physicians Lack knowledge about FDA approval standards for ‘breakthrough therapy’
73 percent incorrectly believed FDA approval meant comparable effectiveness to other approved drugs; 70 percent incorrectly believed approval required both a statistically significant and clinically important effect. Among the 3 breakthrough knowledge questions, 52 percent incorrectly believed that strong evidence… Read More ›
The 8 Assertions of Scientific Misconduct by the Joint Committee on Vaccination and Immunisation – Full 45 Page (FOIA) Document from the University of British Colombia’s Lucija Tomljenovic, PhD
Editor’s Note (Ralph Turchiano) Requested Repost from March 2011 BSEM March 2011 The Health Hazards of Disease Prevention The vaccination policy and the Code of Practice of the Joint Committee on Vaccination and Immunisation (JCVI): are they at odds? Lucija… Read More ›
China police arrest 37 over vaccine scandal
Source: Xinhua 2016-03-23 02:12:33 JINAN, March 23 (Xinhua) — Police in east China’s Shandong Province have detained 37 suspects implicated in a vaccine scandal that has shocked the nation and raised questions over vaccine safety. Shandong police announced last… Read More ›
Doctor raises serious questions about medical awards system
Public Release: 2-Feb-2016 ‘Club culture’ in British medicine must be replaced, argues senior heart doctor BMJ The system that awards national and academic honors to doctors is called into question by a senior doctor writing in The BMJ this… Read More ›
Experts: High drug price trend has ‘infected’ generics
“as companies value profit at the expense of long-term utility to society” Public Release: 27-Jan-2016 Authors highlight concern that pharmaceutical companies use strategies to delay patient access to affordable generic drugs American Society of Hematology (WASHINGTON, January 27, 2016)… Read More ›
Allegations of Scientific Misconduct by GACVS/WHO/CDC Representatives et al
An open-letter of complaint to the Director-General of the World Health Organization, Dr. Margaret Chan chanm@who.int Cc: The Ministry of Health, Labour and Welfare, Japan, www-admin@nhlw.go.jp Minister of Health, Labour and Welfare, Japan, shiozaki@y-shiozaki.or.jp Thomas Frieden,… Read More ›
Parents accused of shaking their baby to death by ‘medic who branded herself TV’s Dr House’ clear their name and now file lawsuit against hospital for ‘series of fatal blunders’
Sara and Padraig Keenan claim daughter Lana died after ‘medical errors’ Couple were then wrongly accused of child abuse leading to her death Doctor branded herself as TV’s Dr House claimed they’d shaken infant Parents were barred from seeing daughter… Read More ›
Blood products and vaccine manufacturer maker Kaketsuken covered up irregularities for 40 years
NATIONAL JAN. 09, 2016 – 02:51PM JST TOKYO — Blood products and vaccine manufacturer Kaketsuken on Friday was ordered by the state to suspend business for 110 days, the longest penalty ever handed down under Japan’s pharmaceutical law, as… Read More ›
Vaccine and blood product maker Kaketsuken raided over decades of alleged faked records, illegal additives
“the panel said that the institute added substances not authorized by the government to flu vaccines and blood products for hemophilia patients” KYODO DEC 3, 2015 The health ministry inspected the premises of a major manufacturer of blood products… Read More ›
Concern over drug industry involvement at India’s ‘health camps’
Public Release: 2-Dec-2015 Unchecked screening and conflict of interests have experts worried, says report BMJ Pharmaceutical sales representatives are screening people in India in return for prescriptions for their products, finds a special report published by The BMJ today…. Read More ›
Skin cancer drugs increase an average of 1,240% in price over 6 years
Public Release: 25-Nov-2015 Changes in retail prices for prescription dermatologic drugs from 2009-2015 The JAMA Network Journals Prices among 19 brand-name prescription dermatologic drugs increased rapidly between 2009 and 2015, with prices for topical antineoplastic drugs to prevent the spread… Read More ›
Big pharma inconsistent with disclosure of information on clinical trials, new study finds
Public Release: 12-Nov-2015 ‘Good Pharma Scorecard’ ranks drugs based on their transparency and ethical practices NYU Langone Medical Center / New York University School of Medicine Despite legal and ethical requirements, information on clinical trials for drugs approved by… Read More ›
Discrepancies are common between reported medical outcomes and trial registry data
Public Release: 20-Oct-2015 “From 2005 to 2014, we found that only 26 percent of randomized trials published in core headache journals were compliant with trial registration requirements, and that 38 percent of registered trials published results that did not match… Read More ›
Company Hikes Price of Life-Saving AIDS, Cancer Drug by 5,000%
A drug that fights a common parasite preying on people with weakened immune systems has spiked in price by 5,000 percent to $750 per pill. Daraprim (pyrimethamine) treats toxoplasmosis, the second most common food-borne disease, which easily affects people… Read More ›
Study 329 – Reanalysis of antidepressant trial finds popular drug ineffective & unsafe for adolescents
Public Release: 16-Sep-2015 Results contradict original findings and have important implications for research and practice BMJ The widely used antidepressant paroxetine is neither safe nor effective for adolescents with depression, concludes a reanalysis of an influential study originally published in… Read More ›
Children on an antidepressant were 11 times more likely to harm themselves over a placebo. The criminal cover up of Study 329
Public Release: 16-Sep-2015 University of Adelaide A University of Adelaide led study has found that a psychiatric drug claimed to be a safe and effective treatment for depression in adolescents is actually ineffective and associated with serious side effects. Professor… Read More ›
Almost 9 in 10 medical guideline creators have a Conflict of Interest
Public Release: 22-Jul-2015 Guidelines: Authors’ conflicts of interest should lead to consequences Deutsches Aerzteblatt International A guideline–recommendations on diagnosing and treating a particular disorder–aims to present the best possible treatment for patients. However, when guidelines are compiled their authors often… Read More ›
Antidepressant trials exclude most ‘real world’ patients with depression
Public Release: 14-Jul-2015 Wolters Kluwer Health July 14, 2015 – More than 80 percent of people with depression in the general population aren’t eligible for clinical trials of antidepressant drugs, according to a study in the Journal of Psychiatric Practice…. Read More ›
Statin Data Criminally Manipulated to Deceive Doctors
Statin Data Criminally Manipulated to Deceive Doctors = Their paper is an analysis of the data in the statin trials which led them to conclude that “statin advocates have used statistical deception to create the illusion that statins are ‘wonder… Read More ›
Statin drug data criminaly manipulated to show exaggerated benefit and reduced risk?
“This means that only one out of 100 people treated with a statin will have one less heart attack. Statin researchers, however, don’t present the 1% effect to the public. Instead they transform the 1% effect using another statistic, called… Read More ›
Corporate crime in the pharmaceutical industry is common, serious and repetitive
Requested Re-print of BMJ 2012;345:e8462 – Original PDF File: Pharma Crime Pays Corporate crime in the pharmaceutical industry is common, serious and repetitive by Peter C. Gøtzsche, Professor MD, DrMedSci, MSc Nordic Cochrane Centre Rigshospitalet, Dept. 7811 Copenhagen 14 Dec 2012 A short version of… Read More ›
FDA often ignored or just not there for many drug approvals and trials
Study examines FDA influence on design of pivotal drug studies An examination of the potential interaction between pharmaceutical companies and the U.S. Food and Drug Administration (FDA) to discuss future studies finds that one-quarter of recent new drug approvals occurred… Read More ›
Corruption of the Health Care Delivery System
” consumer demand for healthcare is manufactured and manipulated, driving up cost, waste and harm ” Public Release: 14-Oct-2014 Higher Integrity Health Care for Evidence-Based Decision Making LEBANON, NH – The foundation of evidence-based research has eroded and the trend… Read More ›
Discrepancies between trial results reported on clinical trial registry and in journals ( nearly all had discrepancies )
– nearly all had at least 1 discrepancy in the study group – Our findings raise questions about accuracy of both ClinicalTrials.gov and publications, as each source’s reported results at times disagreed with the other. During a one year period,… Read More ›
Scandal of experts who rule on NHS statins but get paid by drugs firms
MOST of the experts who are set to recommend the widespread use of statins next month are in the pay of the drug companies that manufacture them. By: Lucy Johnston Published: Sun, March 9, 2014 Dr Anthony Wierzbicki: Chairman… Read More ›
How computer-generated fake papers are flooding academia
More and more academic papers that are essentially gobbledegook are being written by computer programs – and accepted at conferences ‘I’ve written five PhDs on Heidegger just this afternoon. What next?’ Photograph: Blutgruppe – Like all the best hoaxes, there… Read More ›
No standard for the placebo?
Public release date: 18-Oct-2010 HRR- Requested Repost , in regards to how to rig double blind cross over placebo drug trial. – “there isn’t anything actually known to be physiologically inert. On top of that, there are no regulations about… Read More ›
Ghostwritten articles overstate benefits of ( Prempro ) hormone replacement therapy and downplay harms
Public release date: 7-Sep-2010 HRR-Re-Posted at Request – analyzed dozens of ghostwritten reviews and commentaries published in medical journals and journal supplements that were used to promote unproven benefits and downplay harms of Prempro – The analysis revealed that DesignWrite… Read More ›
Dosing schedule of pneumococcal vaccine linked with increased risk of getting multiresistant strain
Public release date: 7-Sep-2010 – EEV: Requested Re-Post from the HRR site. – Infants who received heptavalent pneumococcal conjugate vaccination (PCV-7) at 2, 4, and 11 months were more likely than unvaccinated controls to have nasopharyngeal acquisition of pneumococcal serotype… Read More ›
FDA fails to withdraw unproven blood pressure drug that has been on the market for 18 years in spite of the manufacturer’s failure to submit evidence that it actually helps patients
Public release date: 16-Aug-2010 – HRR: UPDATE As of 15 FEB 2014 ProAmatine or generic versions are still on the market being prescribed – According to the GAO, the FDA has never once pulled a drug off the market due to… Read More ›
WHO and the pandemic flu “conspiracies” – The BMJ and the Bureau of Investigative Journalism report that was covered up
Conflicts of Interest – A joint investigation by the BMJ and the Bureau of Investigative Journalism has uncovered evidence that raises troubling questions about how WHO managed conflicts of interest among the scientists who advised its pandemic planning – The… Read More ›
Doctors Group Sues FDA over ( Daxas, Daliresp) , Roflumilast for COPD
Highlights: -Physicians for Integrity in Medical Research says in its federal complaint against Food and Drug Administration Commissioner Margaret Hamburg – best-case scenario showed that roflumilast reduced the number of exacerbations by one episode a year for every five patients… Read More ›
Eli Lilly and Zyprexa Under the Spotlight / (( Employees WROTE the MEDICAL STUDIES ))
Public release date: 16-Jun-2009 – Reposted at request here, so it can be permalinked… – was done despite Lilly’s access and knowledge of at least seven studies that showed the drug was apparently ineffective for the treatment of dementia –… Read More ›
US ranks near bottom among industrialized nations in efficiency of health care spending
Contact: Carla Denly cdenly@support.ucla.edu 310-825-6738 University of California – Los Angeles UCLA, McGill study also shows women fare worse than men in most countries A new study by researchers at the UCLA Fielding School of Public Health and McGill University… Read More ›
Food and Chemical Toxicology Editor-in-Chief, A. Wallace Hayes, publishes response to letters to the editor / Was Monsanto involved in the retraction?
Contact: Meghan Jendrysik m.jendrysik@elsevier.com 617-397-2845 Elsevier Cambridge, MA, December 10, 2013 – The following statement will be published in the journal, Food and Chemical Toxicology, alongside a selection of letters to the editors regarding the decision to retract the paper… Read More ›
Swine flu pandemic media pundits with pharma links more likely to talk up risks and promote drugs
Contact: Stephanie Burns sburns@bmj.com 44-020-738-36529 BMJ-British Medical Journal Competing interests should be declared — and reported — to maintain credibility of public health, say researchers Academics with links to the pharmaceutical industry were more likely to talk up the… Read More ›
Wider use of statins ‘disturbing’
Wider use of statins will have minimal benefit and could needlessly expose thousands to severe side effects, doctors warn following change in US prescription guidelines New US guidelines on statins, issued on Tuesday by the American College of Cardiology and… Read More ›
Blue Cross Conspired to Destroy Company Serving Hemophiliacs, Firm Says
By IULIA FILIP WEST PALM BEACH (CN) – Blue Cross Blue Shield destroyed a health care company by refusing to pay claims of its hemophiliac patients and conducting a “witch hunt” that destroyed its reputation, the… Read More ›
Unpublished trial data ‘violates an ethical obligation’ to study participants, say researchers / 1 in 3 large clinicals not Published
Contact: Stephanie Burns sburns@bmj.com 44-020-738-36920 BMJ-British Medical Journal Study finds almost 1 in 3 large clinical trials still not published 5 years after completion Almost one in three (29%) large clinical trials remain unpublished five years after completion. And… Read More ›
“Merck and Schering-Plough must pay $688 million for lying to shareholders about the benefits of cholesterol drug Vytorin over its cheaper, generic version”
$688 Million Settlement Approved in Merck Case By ROSE BOUBOUSHIAN (CN) – Merck and Schering-Plough must pay $688 million for lying to shareholders about the benefits of cholesterol drug Vytorin over its cheaper, generic version, a federal judge ruled. The… Read More ›
40 years of CDC nutrition research fatally flawed
Contact: Jeff Stensland stenslan@mailbox.sc.edu 803-777-3686 University of South Carolina 40 years of federal nutrition research fatally flawed University of South Carolina study shows flaws in NHANES data Four decades of nutrition research funded by the Centers for Disease Control and… Read More ›
Current study shows: Important information on effects and side effects of drugs is missing in most publications
IQWiG: Reliable assessment of drugs is only possible on the basis of clinical study reports (CSRs) In 2012 researchers from the German Institute for Quality and Efficiency in Health Care (IQWiG) presented a study in the BMJ analysing information sources… Read More ›
The widespread acceptance of an atrocious manuscript, fabricated by an investigative journalist, reveals the near absence of quality at some journals
Fake Paper Exposes Failed Peer Review By Kerry Grens | October 6, 2013 Having an authentic name, representing a real research institution, and offering actual scientific results are apparently not required for publication in many open access journals, Science… Read More ›
Drug companies paid big bucks to attend FDA painkiller meetings
Article by: Peter Whoriskey Washington Post October 6, 2013 – 11:15 PM WASHINGTON – A scientific panel that shaped the federal government’s policy for testing the safety and effectiveness of painkillers was funded by major pharmaceutical companies that paid… Read More ›
Japan to raid Novartis over alleged data fabrication
27 Sep 2013 Tokyo (AFP) Japanese authorities are preparing to raid the local arm of Swiss pharmaceutical giant Novartis over data fabrication claims, reports said Friday. A health ministry panel of experts has concluded that Novartis Pharma KK should be held… Read More ›
Eli Lilly ‘concerned’ by China bribery allegations
23 Aug 2013 SHANGHAI (AFP) US drugmaker Eli Lilly said it was “deeply concerned” about allegations it bribed Chinese doctors to prescribe its products, the latest accusations of malpractice by foreign firms in the country. A former Eli Lilly sales manager… Read More ›
Engineering Evil 